Search NASA⌕ Search

Engineering topics

Chen, Y -J

Publications and source records attributed to Chen, Y -J.

ULTRA-COMPACT ACCELERATOR TECHNOLOGIES FOR APPLICATION IN NUCLEAR TECHNIQUES

We report on compact accelerator technology development for potential use as a pulsed neutron source quantitative post verifier. The technology is derived from our on-going compact accelerator technology development program for radiography under the US Department of Energy and for a clinic sized compact proton therapy systems under an industry sponsored Cooperative Research and Development Agreement. The accelerator technique relies on the synchronous discharge of a prompt pulse generating stacked transmission line structure with the beam transit. The goal of this technology is to achieve approx10 MV/m gradients for 10 s of nanoseconds pulses and approx100 MV/m gradients for approx1 ns systems. As a post verifier for supplementing existing x-ray equipment, this system can remain in a charged, stand-by state with little or no energy consumption. We describe the progress of our overall component development effort with the multilayer dielectric wall insulators (i.e., the accelerator wall), compact power supply technology, kHz repetition-rate surface flashover ion sources, and the prompt pulse generation system consisting of wide-bandgap switches and high performance dielectric materials.

43 PARTICLE ACCELERATORS↗

X-Ray Structure of EmrE Support Dual Topology Model

EmrE, a multidrug transporter from Escherichia coli, functions as a homodimer of a small four-transmembrane protein. The membrane insertion topology of the two monomers is controversial. Although the EmrE protein was reported to have a unique orientation in the membrane, models based on electron microscopy and now defunct x-ray structures, as well as recent biochemical studies, posit an antiparallel dimer. We have now reanalyzed our x-ray data on EmrE. The corrected structures in complex with a transport substrate are highly similar to the electron microscopy structure. The first three transmembrane helices from each monomer surround the substrate binding chamber, whereas the fourth helices participate only in dimer formation. Selenomethionine markers clearly indicate an antiparallel orientation for the monomers, supporting a 'dual topology' model.

59 BASIC BIOLOGICAL SCIENCES↗

Resveratrol-Induced Apoptosis and Increased Radiosensitivity in CD133-Positive Cells Derived From Atypical Teratoid/Rhabdoid Tumor

Purpose: CD133 has recently been proposed as a marker for cancer stem-like cells (CSC) in brain tumors. The aim of the present study was to investigate the possible role of resveratrol (RV) in radiosensitivity of CD133-positive/-negative cells derived from atypical teratoid/rhabdoid tumors (AT/RT-CD133{sup +/-}). Materials and Methods: AT/RT-CD133{sup +/-} were isolated and characterized by flow cytometry and quantitative real-time reverse transcription-polymerase chain reaction, and then treated with RV at different doses. Migratory ability, colony formation, apoptotic activity, and xenotransplantation were assessed for RV alone, ionizing radiation (IR) alone, and IR with RV conditions. Results: AT/RT-CD133{sup +} displayed enhanced self-renewal and highly coexpressed 'stem cell' genes and drug-resistant genes, in addition to showing significant resistance to chemotherapeutic agents and radiotherapy as compared with CD133{sup -} cells. After treatment with 200 {mu}M RV, the in vitro proliferation rates and in vivo tumor restoration abilities of ATRT-CD133{sup +} were dramatically inhibited. Importantly, treatment with 150 {mu}M RV can effectively inhibit the expression of drug-resistant genes in AT/RT-CD133{sup +}, and further facilitate to the differentiation of CD133{sup +} into CD133{sup -}. In addition, treatment with 150 {mu}M RV could significantly enhance the radiosensitivity and IR-mediated apoptosis in RV-treated ATRT-CD133{sup +/-}. Kaplan-Meier survival analysis indicated that the mean survival rate of mice with ATRT-CD133{sup +} that were treated with IR could be significantly improved when IR was combined with 150 {mu}M RV treatment. Conclusions: AT/RT-CD133{sup +} exhibit CSC properties and are refractory to IR treatment. Our results suggest that RV treatment plays crucial roles in antiproliferative, proapoptotic, and radiosensitizing effects on treated-CD133{sup +/-}; RV may therefore improve the clinical treatment of AT/RT.

62 RADIOLOGY AND NUCLEAR MEDICINE↗